NumerixS Investment Technologies’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

NumerixS Investment Technologies’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,064	Closed	-$151K	–	1039
2020 Q2	$151K	Buy	+2,064	New	+$110K	0.04%	458
2020 Q1	–	Sell	-7,104	Closed	-$387K	–	1409
2019 Q4	$387K	Buy	7,104 +4,204	+145%	+$208K	0.08%	295
2019 Q3	$121K	Buy	+2,900	New	+$123K	0.03%	512
2019 Q2	–	Sell	-2,600	Closed	-$134K	–	1488
2019 Q1	$134K	Buy	2,600 +2,000	+333%	+$86.4K	0.02%	789
2018 Q4	$21K	Sell	600 -2,000	-77%	-$72.1K	0.01%	922
2018 Q3	$98K	Buy	+2,600	New	+$95.6K	0.02%	816
2017 Q3	–	Sell	-2,400	Closed	-$60K	–	1489
2017 Q2	$60K	Buy	+2,400	New	+$55.3K	0.01%	934

Other funds holding BHVN

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NumerixS Investment Technologies's BHVN Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2020, closing a stake of 2,064 shares — an estimated $151K sold.

NumerixS Investment Technologies first reported a position in BHVN in Q2 2017 and held it in 7 quarters. The position peaked at $387K in Q4 2019. 215 funds tracked by Wall St. Rank hold BHVN as of Q3 2020.

NumerixS Investment Technologies reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2020 after selling out during the quarter.
NumerixS Investment Technologies sold 2,064 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2020, an estimated $151K.
NumerixS Investment Technologies first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 7 quarters.
NumerixS Investment Technologies's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $387K in Q4 2019.
215 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.